From COVID to cancer, new at-home test detects disease with startling accuracy – BioNews Central A new low-cost biosensing technology could make rapid at-home tests up to 100 times more sensitive to viruses like COVID-19 and extend rapid screening to serious conditions such as prostate cancer and sepsis.

A new low-cost #biosensing technology could make rapid #AtHomeTests up to 100 times more sensitive to #viruses like #COVID19 and extend rapid screening to serious conditions such as #ProstateCancer and #sepsis. 
#PointOfCareDiagnostics

There are #AtHomeTests available for all sorts of health concerns! At-home tests may be quicker, easier, or cheaper than a doctor’s visit. Use only FDA-approved tests to ensure the quality and accuracy of results, and follow up with your doctor with questions.

Source: iHeard St. Louis Project